Honorary Professor of Medicine, Barts and The London School of Medicine and Dentistry; Emeritus Professor of Endocrinology, St George’s University of London, UK
|Rosalia CM Simmen
University of Arkansas for Medical Sciences, USA
Dr Rosie Simmen is currently Professor in the Department of Physiology and Cell Biology and an Associate Faculty of the Winthrop P Rockefeller Cancer Institute (Cell Biology Program), University of Arkansas for Medical Sciences. She also serves as Program Director of Cell Biology & Physiology Track of the Graduate Program in Interdisciplinary Biomedical Sciences and as Departmental Vice-Chair of Education. Professor Simmen’s research interests centre around mechanistic aspects of women’s health with focus on metabolic linkages with hormone-dependent breast and gynecological cancers and reproductive disorders including endometriosis and infertility. She has served most recently as Senior Editor of Journal of Endocrinology and Journal of Molecular Endocrinology and as Editorial Board member in many other reproductive and endocrine-based journals.
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Germany
Professor Ute Scholl is currently BIH Johanna Quandt Professor for Hypertension and Molecular Biology of Endocrine Tumors. Her laboratory team works on the genetics and pathophysiology of hypertension and endocrine tumors, and is particularly interested in primary aldosteronism. Major discoveries include the identification of ion channel mutations as causes of sporadic and familial primary aldosteronism.
University of Turin – San Luigi Hospital, Italy
Professor Massimo Terzolo is director of the Division of Internal Medicine at San Luigi Hospital, and Full Professor of Internal Medicine at the University of Turin. Professor Terzolo is a clinical and translational researcher specialized on adrenal diseases with major expertise in management of patients with adrenal tumours. Recent work from his group has provided significant advances in the development of new therapeutic strategies for adrenal carcinoma and in the definition and management of subclinical Cushing syndrome.
Evangelismos Hospital, Athens, Greece
Dr Stelios Tsagarakis is currently serving as Head of the Department of Endocrinology and Diabetes and coordinator of the National Expertise Centre for Rare Endocrine Diseases at Evangelismos Hospital in Athens. He has a major interest in pituitary tumours especially Cushing’s disease and in adrenal disorders especially adrenal incidentalomas with a focus on diagnosis and management of mild autonomous cortisol secretion.
|Bone and Mineral Metabolism|
Hospital das Clínicas, University of Sao Paulo (USP) School of Medicine, Sao Paulo, Brazil
Clinically trained in Endocrinology at USP, Dr Ferraz-de-Souza received his PhD in Endocrinology from University College London (UCL), UK. He is Tenured Principal Investigator and Consultant in Endocrinology at the Hospital das Clínicas. He is an Associate Editor for Archives of Endocrinology and Metabolism, the official journal of the Brazilian Society of Endocrinology and Metabolism (SBEM), and for the Journal of the Endocrine Society, (JES). Dr Ferraz-de-Souza's research interests include the management of metabolic bone disorders and the molecular diagnosis of rare and common endocrinopathies.
Christie Hospital NHS Foundation Trust, UK
Dr Claire Higham is currently an Endocrine Consultant at the Christie Hospital NHS Foundation Trust, Manchester, and Honorary Senior Lecturer at the University of Manchester. Dr Higham’s research and clinical interests centre around Living With and Beyond Cancer Science, particularly the effects of Cancer and Cancer treatments on bone health and the pituitary. Dr Higham holds an MRC-CARP award investigating the impact of radiotherapy on bone health and is supervising an NIHR-affiliated fellowship determining long term bone health in adult haematological cancer survivors. Dr Higham has recently published an SfE clinical guidance document in Endocrine Connections: Acute management of the endocrine complications of checkpoint inhibitor therapy.
Technische Universitat Dresden, Germany
Dr Martina Rauner is the Scientific Director of the Bone lab of the Division of Endocrinology, Diabetes, and Bone Diseases at the Department of Medicine III, Medical Faculty of the Technische Universität Dresden. The lab is currently focusing on the role of the Wnt signaling pathway in the pathogeneses of metabolic, inflammatory, haematological, and malignant bone diseases.
Alexander Bartelt is the Professor of Cardiovascular Metabolism at the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich. He received his Diploma in Biochemistry in 2007 and his PhD in 2010 from University of Hamburg, Germany with honors. After his postdoctoral training at Harvard University, USA he started as a principal investigator in Munich in 2018. The Bartelt lab is dedicated to understanding the basic principles of metabolic adaptation as well as the molecular pathology of cardiometabolic diseases. One primary scientific focus of the lab is the interplay of proteostasis, inflammation and cellular stress resistance and this research is currently supported by the European Research Council ERC, the German Center for Cardiovascular Research DZHK, the German Research Foundation DFG. Over the years, Dr Bartelt’s contributions have been recognized by national and international awards, fellowships and honors.
|Hormones and Cancer|
Tohoku University, Japan
Dr Keely McNamara has extensive experience in investigating various aspects of intracrine mechanisms of hormone dependent neoplasms in both prostate and breast. Following her PhD studies examining steroid metabolism in the prostate in mouse models of prostate neoplasia she moved to Japan first as a JSPS-AAS postdoctoral fellow and later as an Assistant Professor at Tohoku University. Her primary focus is translational research studying steroid metabolism and actions in the breast and in breast cancer.
Monash University, Australia
Associate Professor Renea Taylor is currently Deputy Head of the Cancer Program, Biomedicine Discovery Institute, Monash University and Research Fellow in the Department of Physiology. A/Prof Renea Taylor’s research interests centre around hormone-dependent cancers, particularly prostate cancer. Her studies focus on dissecting appropriate cellular targets in cancer, including stromal cells and stem cells, and subsequently identifying novel therapeutic strategies to treat prostate cancer. More recently, her team has focused on elucidating the endocrine and metabolic changes that contribute to prostate cancer disease progression, including fatty acid metabolism. She is the past Program Convener of the Endocrine Society of Australia (ESA) and has been awarded the Servier Award, the Novartis Award and the Australian Women in Endocrinology New Investigator Travel Award from the ESA.
|Metabolic Syndrome and Diabetes|
Miguel Hernandez University, Spain
After a postdoctoral training in the Department of Nutrition at Karolinska Institutet, Stockholm (Sweden), about the physiology of estrogen receptor ERβ, Professor Alonso-Magdalena is now an Associate Professor of Nutrition and principal investigator at Miguel Hernández University, Spain. She is interested in understanding the role that endocrine disrupting chemicals (EDCs) have in the etiology of diabetes, obesity and related metabolic disorders. Her work has been decisive for linking the exposure to certain widespread endocrine disruptors like bisphenol-A to the etiopathology of type 2 diabetes by using cellular and animal models.
National University of La Plata, Argentina
Dr Antonio Desmond McCarthy is Coordinator of Biochemistry graduate career, Full Professor of Clinical Chemistry and co-Director of LIOMM (Mineral Metabolism and Osteopathy Research Laboratory) in the National University of La Plata. He is also Director of the Buenos Aires Ministry of Health "Horacio Cestino" General Hospital. Professor McCarthy’s research interests have centred around screening strategies for gestational Diabetes; pinpointing the accumulation of AGEs in bone as a relevant mechanism for diabetic osteopathy; and identifying treatment strategies for bone repair, leading to the discovery of osteogenic effects of metformin. He is currently studying the reciprocal regulation between osteopenia and vascular calcifications, and its modulation by metformin.
University of Latvia
Valdis Pirags is Professor of Endocrinology and the Chair of Internal Medicine at the University of Latvia, and director of the Clinic of Internal Medicine at the Pauls Stradiņš Clinical University Hospital. Professor Pirags is credited with discovering of the PKC-dependent cellular mechanisms of platelet activation by glucose and revealing that probability of side effects of metformin are genetically predisposed. These research achievements resulted in establishing of a unique Laboratory of Personalised Medicine at his department. His current interests are focused on revealing of self-regulated psychoneuroendocrine mechanisms counteracting to pathogenesis and exacerbation of chronic diseases.
University of Colorado, USA
Dr Shah is an Associate Professor at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Colorado, USA. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes. He has served on many leadership positions such as steering committee member for Type 1 Diabetes Exchange Clinic Registry (2016-2017), Communication director for diabetes technology interest group at the American Diabetes Association (2019-2020), and American College of Endocrinology Self-Assessment Program writing committee member (2020-2021). He is a recipient of prestigious AACE Rising Start in Endocrinology award (2021). He is well published with over 100 research publications including original article, invited reviews, editorials, and book chapters.
Aarhus University, Denmark
Dr Søndergaard is an endocrinologist at Steno Diabetes Centre Aarhus and Associate Professor at Department of Clinical Medicine at Aarhus University. His research interest is centred around human studies of integrated physiology and substrate metabolism in diabetes. He has published paper on lipid and lipoprotein metabolism and the consequences of diabetes, insulin resistance and inflammation in adipose tissue. He is currently performing studies on ketone body and lactate metabolism and the metabolic consequences of increasing ketogenesis by pharmacological treatment and lifestyle interventions using stable isotope and PET tracer techniques. He also has an interest in adrenal disease. He has been awarded the Jens Sandahl Christiansen Award from the European Society of Endocrinology.
Department of Medicine, Ampla Health Center, Ocala, USA
Dr Gopinath Sunil is currently the Medical Director of Diabetes National Alliance based in Ocala, Florida, USA and is also conducting research in obesity, thyroid disorders and diabetes at the Department of Endocrinology, KIMS hospital, Trivandrum, India. He was previously head of the department of Endocrinology at Physicians Regional Medical Center at Naples, FL and also had served as Assistant Professor, regional Physician training at the University of Minnesota. Dr Sunil’s research interests include reproductive endocrinology (University of Geneva, Switzerland and Stanford University, Palo Alto, USA), type 2 Diabetes and obesity (University of Minnesota and Cleveland Clinic, Florida) and thyroid disorders. He is also internationally known for his work on type 2 diabetes and obesity research and is currently involved with obesity and type 2 DM research and teaching at the Kerala Institute of Medical Sciences in India and Gulf countries.
Queen Mary Hospital, Hong Kong
Kathryn Tan is Sir David Todd Professor in Medicine and Head of the Division of Endocrinology and Metabolism at the University of Hong Kong. Her main research interests include lipid disorders and lipoprotein metabolism, and the role of dyslipidaemia and post-translational modification derived products in the pathogenesis of vascular disease and diabetic complications. She is currently serving on the Executive Board of the Asian Association for the Study of Diabetes. She has recently published in Diabetes Care and in Clinical Journal of the American Society of Nephrology on the pathological role of carbamylated lipoproteins in diabetes.
Queen Mary University, UK
Dr Li Chan is currently Reader in Molecular Endocrinology and Metabolism at Queen Mary University of London. She is also an honorary Paediatric Endocrinologist at Barts Health. Dr Chan’s research interests are centred around paediatric adrenal and metabolic disorders. She was recipient of a number of prestigious fellowships including an MRC Clinical Training Fellowship followed by an Academy of Medical Sciences/MRC Tenure-Track Clinician Scientist Fellowship. She was awarded a JOE/JME prize for a researcher who has made a significant contribution to research in basic endocrinology.
UCL Great Ormond Street Institute of Child Health, UK
Mehul Dattani is Professor of Paediatric Endocrinology based at the University College London (UCL) Great Ormond Street Institute of Child Health, and Specialty Lead in Endocrinology at Great Ormond Street Hospital for Children (GOSH). He has an active clinical practice in paediatric and adolescent Endocrinology at GOSH and University College London Hospitals (UCLH). He completed terms as Chair of the British Society for Paediatric Endocrinology and Diabetes, followed by a 7-year term as Chair of the Programme Organizing Committee and member of the Council of the European Society for Paediatric Endocrinology (ESPE). He is the current President of ESPE. Professor Dattani has established a laboratory group investigating the molecular basis of hypothalamo-pituitary disease at UCL. He has published more than 300 original articles, scholarly reviews and book chapters. He has also co-authored 3 textbooks to date, including the 7th Edition of Brook’s Clinical Paediatric Endocrinology.
|Pituitary and Hypothalamus|
University of Buenos Aires, Argentina
Professor Eduardo Arzt is a member of the Research Scientific Career of the National Research Council of Argentina, Professor at the University of Buenos Aires, Visiting Professor at the Max Planck Institute of Psychiatry in Munich, Germany, External Scientific Member of the Max Planck Society and Director of the BioMedicine Institute of Buenos Aires – CONICET – a Partner Institute of the Max Planck Society. His interest is in the molecular biology of pituitary tumors and hormone production.
Karolinska University Hospital, Sweden
Associate Professor Charlotte Höybye is a Senior Consultant in Endocrinology in the Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden. Her primary clinical and research interests are in pituitary and hypothalamic diseases, including Prader–Willi Syndrome. She is president of The Swedish Society of Endocrinology.
|Jens Otto Lunde Jørgensen
Aarhus University Hospital, Denmark
Jens Otto Lunde Jorgensen is Professor and Chair of the Department of Clinical Medicine and the Department of Endocrinology and Diabetes. Professor Jørgensen’s main research interests include growth hormone (GH), GH-deficiency, metabolic actions of GH and acromegaly, with further work in insulin resistance states, obesity, Cushing and ghrelin.
|Kok Onn Lee
National University of Singapore
K O Lee is Professor at the National University of Singapore, and Consultant Endocrinologist at the National University Hospital in Singapore. His clinical interests are in Pituitary and Gonadal Endocrinology, and his research interests include the GH/IGF/IGFBP axis in fertility, and stem cells and gene therapy in Diabetes. He is a past president of the Endocrine and Metabolic Society of Singapore.
Garvan Institute of Medical Research and St Vincent’s Hospital, Sydney, Australia
Professor McCormack graduated from the University of Sydney, Australia. She was then appointed to her current position as senior staff specialist in the Department of Endocrinology at St Vincent’s Hospital in 2011, and also heads The Hormones and Cancer Group at the Garvan Institute of Medical Research. Her primary research interests are in exploring the biology and new treatment options for aggressive pituitary tumours. She also has research interests in pituitary tumour genetics. She is President-Elect of the Endocrine Society of Australia.
University of Lübeck, Germany
Professor Henrik Oster serves as the Lichtenberg Endowed Chair of Neurobiology and director of the Institute of Neurobiology at the University of Lübeck. After receiving his PhD in biochemistry in Fribourg (CH) and postdoctoral training in Hannover (DE) and Oxford (UK) he started his work in chronophysiology in Göttingen (DE) and, since 2011, in Lübeck (DE). His special interests are in the interaction of endocrine and circadian systems in the regulation of energy metabolism, behavioural functions, and sleep.
University of Science and Technology of China
Jiang-Ning Zhou is Professor of Neurobiology at the University of Science and Technology of China, serving as head of of Key Laboratory of Brain Function and Brain Diseseas of the Chinese Academy of Sciences since 2009. He received a PhD in Neuroscience from the University of Amsterdam. His research interests is the neural circuit of corticotropin-releasing hormone neuron in stress and depression related behaviour. Jiang-Ning Zhou is a honorable member of the Chinese Neuroscience Society and the chair of the Neuroscience Society of Anhui Province. He has published more than 100 peer-reviewed publications as well as several books.
Imperial College London, UK
Stephen Franks is professor of reproductive endocrinology at Imperial College London, Faculty of Medicine and a former chairman of the Society for Endocrinology. He is a fellow of the Academy of Medical Sciences and holds an honorary doctorate from the University of Uppsala, Sweden. He has clinical and laboratory-based programmes of research in the field of normal and disordered function of the hypothalamic-pituitary-ovarian axis with a major interest in polycystic ovary syndrome (PCOS), a common endocrine disorder with both reproductive and metabolic effects. His research focuses on the interaction between genetic and environmental factors in aetiology of the syndrome.
University of Aarhus and Aarhus University Hospital, Denmark
Dr Claus Gravholt is Associate Professor at the University of Aarhus, and consultant in the Department of Endocrinology and in the Department of Molecular Medicine, Aarhus University Hospital. His clinical and research interests are sex hormone physiology and consequences of sex hormone deficiency as well as diabetes during pregnancy and the effects thereof on the child. He is also studying the genetics of endocrine diseases, such as Turner and Klinefelter syndrome and 46,XY females, as well as the epidemiology of these diseases. He is a member of the European Society of Endocrinology, the US Endocrine Society.
National and Kapodistrian University of Athens, Greece
Professor George Mastorakos is currently Professor of Endocrinology and Director of the post-graduate University Master Research in Female Reproduction at the National and Kapodistrian University of Athens. Professor Mastorakos’ research interests include endocrinology of reproduction, pregnancy and menopause, obesity, neuroendocrine mechanisms in chronic/acute stress and immune/inflammatory reaction, endocrinology of exercise, hypothalamic amenorrhea. He has served as member on the International Advisory Panel for Endocrine Reviews. He served as president of the Hellenic Endocrine Society and ex-officio member of the European Society of Endocrinology (ESE) ExCo. He has been the recipient of a Special Recognition Award from ESE.
University of Marburg, Germany
Professor Andreas Meinhardt studied Human Biology at Philipps University in Marburg. After his postdoctoral stay at Monash University in Melbourne, Australia, he returned to Marburg and was later appointed as professor at Justus-Liebig-University Giessen, Germany. Research interest includes reproductive immunology with a focus on infection and inflammation of the epididymis and testis as a cause of infertility. He holds two Honorary Professorships with Monash University, has served on the councils of the German Society of Andrology (2005-20012) and European Academy of Andrology (2002-2010), and is the current President of the International Society of Andrology.
Brigham and Women’s Hospital, Harvard Medical School, USA
Sara Ahmadi is currently an Endocrine faculty at Brigham and Women’s Hospital Harvard Medical School. She was previously an Assistant Professor of Medicine at Duke University, a member of the Duke Endocrine Neoplasia team, and the Duke Cancer Institute. Dr Ahmadi’s research interests have centred around patient-centred outcomes through the study of patient-reported outcome, radiologic and sonographic characteristics of thyroid nodules which can be used as predictors of thyroid cancer and clinical, pathological and molecular factors that may predict outcome in patients with thyroid cancer.
Jagiellonian University, Poland
Professor Alicja Hubalewska-Dydejczyk is Chair of the Department of Endocrinology, Jagiellonian University, Medical College in Cracow, Poland. She is a specialist in internal medicine, endocrinology and nuclear medicine and her major research interest is thyreology, with special concerns in the management of thyroid dysfunction in pregnancy and in optimization of the iodine prophylaxis in Europe. Since 1999 she has worked on optimization of diagnostic and therapeutic algorithm of neuroendocrine tumour patients including radioisotope imaging method and peptide receptor radionuclide therapy. Suprarenal glands and pituitary disorders are an additional area of interest.
|Won Bae Kim
Asan Medical Center, University of Ulsan, Korea
Dr Kim's research focuses on markers of prognostic significance and on novel therapeutic target in thyroid cancer, specifically specific changes in cancer cell metabolism. He is part of a multi-disciplinary team of thyroid cancer specialists in Asan Medical Center. He served as Chief of Board of Directors of the Korean Thyroid Association from 2015 to 2017, organized the 12th Asia and Oceania Thyroid Association Congress (AOTA) in 2017 and has served as secretary general of AOTA since 2015. He received the Nagataki-Fujifilm prize of AOTA in 2019.
M Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland
Dr Krajewska is board-certified in endocrinology and internal diseases. She has been deeply involved in the treatment of thyroid carcinoma for more than 20 years. The subject of her habilitation thesis concerned kinase tyrosine inhibitor therapy for advanced thyroid carcinoma, especially treatment-related side effects. Dr Krajewska’s research interest focuses on the management of advanced differentiated and medullary thyroid cancer, including the treatment with tyrosine kinase inhibitors, other endocrine malignancies, and molecular background of thyroid carcinomas, particularly radioiodine-refractory differentiated thyroid cancer and medullary thyroid cancer.
University of Cordoba, Argentina
Professor Claudia Pellizas is Associate Professor at the National University of Cordoba (UNC), Argentina, and Principal Researcher from the National Research Council (CONICET) at the Center of Clinical Biochemistry and Immunology (CIBICI). She leads a research group interested in the study of thyroid hormone functionality in normal and pathological conditions. The main focus is the study of thyroid hormone action at the initiation of the immune response, and the role of the tumor microenvironment in the development of thyroid cancer, including immune cells. She has been the mentor of several Doctoral Theses (PhD in Chemical Sciences, UNC), postdoctoral fellowships (CONICET), and young CONICET researchers that covered the aforementioned topics.
Mount Sinai School of Medicine, USA
Dr Robert Rapaport is Professor of Pediatrics and Chief of the Division of Pediatric Endocrinology and Diabetes as well as the Program Director for the Fellowship Program at the Mount Sinai School of Medicine. He holds the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes Chair at the Mount Sinai School of Medicine. His areas of expertise include growth, growth hormone, neonatal thyroid disease, childhood diabetes and pubertal disorders.
Institute for Community Medicine, University Medicine Greifswald, Germany
Dr Alexander Teumer is a researcher and is leading a group focusing on genetic epidemiology at the Institute for Community Medicine of the University of Medicine, Greifswald. Having a background in mathematics and computer science, he participated in and led various projects on determining the genetic background of complex traits and diseases. Currently, his main research focus is on thyroid and kidney function. He is the co-leader of the ThyroidOmics consortium studying the determinants and effects of thyroid diseases and function.
Open University, UK
Heather Whitaker is a senior lecturer in Statistics at the Open University in the UK. She is a medical statistician with research interests in study design and applications in epidemiology, particularly pharmaco-epidemiology, vaccine safety, infectious diseases and environmental epidemiology. She is an expert in self-controlled study designs that are used to study the temporal association between acute outcomes and transient exposures. She studied at Sussex and Imperial College and teaches statistics by distance learning at the Open University.
Editors' declarations are listed in the journal's Disclosure Policy.